FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/12/2023
Back to search
Official data from USPTO
OM PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
04/12/2023
Trademark type
Combined
Nice classes
5, 10, 44
Filing date
05/18/2021
Registration date
11/29/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2022
Last transaction
11/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH
Examiner
PARKS, KIMBERLY
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "OM PHARMA" with a drop design breaking through the top center of the letter "O".
Holders and representatives
Holders
OM Pharma SA
Representatives
Erica Halstead Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of microangiopathiesdiabetic retinopathysymptoms of chronic venous insufficiency in the lower limbsnamely paincrampsparaesthesiaoedemastasis dermatosissuperficial thrombophlebitispost-thrombotic syndromemicrocirculatory disorders of arteriovenous origin and hemorrhoidal syndromehemorrhoidal syndromehemorrhoidectomycapillary hemorrhages caused by menorrhagiametrorrhagiavascularised tissuesepistaxis and periventricular hemorrhage in newbornsrecurrent respiratory tract infectionsasthmarecurrent wheezingatopic dermatitisrecurrent and chronic urinary tract infectionsacute urinary tract infections; sanitary preparations for medical purposes; medical plasters; food for babies; materials for dental fillings and dental impressions; disinfectants
Class 10
Medical devices to administer pharmaceutical preparationsnamely inhalers; artificial limbseyes and teeth; suture materials
Class 44
Medical and veterinary services; hygienic and beauty care services for human beings or animals
Publications
History of USPTO decisions and trademark events.
27 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/21/2023
FIMP
FINAL DISPOSITION PROCESSED
03/21/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/29/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/29/2022
GPNX
NOTIFICATION PROCESSED BY IB
10/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/13/2022
PUBO
PUBLISHED FOR OPPOSITION
09/13/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/24/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2022
RFNT
REFUSAL PROCESSED BY IB
03/21/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/02/2022
RFRR
REFUSAL PROCESSED BY MPU
03/02/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/03/2022
CNRT
NON-FINAL ACTION WRITTEN
02/02/2022
DOCK
ASSIGNED TO EXAMINER
01/28/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/04/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/27/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/22/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/15/2021
Continuous trademark protection
Get notified about every new filing that threatens OM PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.